Table 1 Baseline characteristics of patients with LMCAD that underwent CABG or PCI
Variables | CABG (N = 1180) | PCI (N = 526) | P value |
|---|---|---|---|
Age, years | 67 ± 9 | 71 ± 11 | 6.94e-16 |
Female | 181 (15.3) | 150 (28.5) | 2.07e-10 |
Hypertension | 690 (58.5) | 306 (58.2) | 0.908 |
Dyslipidemia | 720 (61) | 314 (59.7) | 0.606 |
Heart failure | 36 (3.1) | 44 (8.4) | 1.63e-06 |
Atrial fibrillation | 3 (0.3) | 5 (1) | 0.052 |
Type I or II Diabetes | 301 (25.5) | 143 (27.2) | 0.466 |
COPD | 67 (5.7) | 43 (8.2) | 0.053 |
CEVD | 29 (2.5) | 22 (4.2) | 0.053 |
CKD | 6 (0.5) | 11 (2.1) | 0.002 |
PAD | 38 (3.2) | 24 (4.6) | 0.171 |
Any Liver disease | 0 (0) | 1 (0.2) | 0.134 |
Malignancy | 4 (0.3) | 12 (2.3) | 0.0001 |
Current smoker | 228 (19.3) | 78 (14.8) | 0.026 |
Former smoker | 326 (27.6) | 145 (27.6) | 0.979 |
Baseline Medications | |||
ASA | 787 (66.7) | 348 (66.2) | 0.829 |
Other antiplatelets | 305 (25.8) | 187 (35.6) | 4.39e-05 |
Statin | 626 (53.1) | 290 (55.1) | 0.426 |
ACEi/ARB | 569 (48.2) | 277 (52.7) | 0.09 |
Beta-blocker | 634 (53.7) | 300 (57) | 0.205 |
Anticoagulant | 81 (6.9) | 67 (12.7) | 6.89e-05 |
